期刊文献+

早发冠心病患者介入无置入策略的应用进展

下载PDF
导出
摘要 据心血管疾病和风险的全球负担[1]显示,缺血性心脏病仍然是全人类最主要的致残和致死原因。冠状动脉疾病(coronary artery disease,CAD)是从儿童时期开始发展,并在一生中不断进展的疾病[2]。流行病学调查表明,CAD在年轻人中越来越多见,这对我国的心血管疾病诊疗带来了巨大挑战。早发冠心病(premature coronary artery disease,PCAD),即在年轻人群中出现的冠状动脉疾病,其评估及治疗不同于老年CAD。由于年轻人群的生存预期更长,因此其冠心病的介入治疗应该更加谨慎和慎重,尽量避免置入支架,以减少长期并发症的风险及心理负担。
出处 《心肺血管病杂志》 CAS 2024年第8期889-892,共4页 Journal of Cardiovascular and Pulmonary Diseases
基金 国家重点研发计划“主动健康和人口老龄化科技应对”重点专项(国家重点研发计划)(2022YFC3602500)。
  • 相关文献

参考文献4

二级参考文献34

  • 1王淼,王薇,赵冬,吴桂贤,刘静,孙佳艺,刘军,刘飒,秦兰萍,吴兆苏.北京地区青年人群心血管病危险因素10年变化趋势[J].心肺血管病杂志,2005,24(2):65-67. 被引量:27
  • 2Choi J, Daskalopoulou SS, Thanassoulis G, et al. Sex- and gen- der-related risk factor burden in patients with premature acute coronary syndrome. Can J Cardiol, 2014,30 : 109-117.
  • 3Manson JE1, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med, 2003, 349:523-534.
  • 4Manson JE, Chlebowski RT, Aragaki AK. Hormone therapy use and outcomes in the Women's Health Initiative trials-reply. JA- MA, 2014, 311:417-418.
  • 5Ertelt K, G6n6reux P, Mintz GS, et al. Clinical profile and im- pact of family history of premature coronary artery disease on clin- ical outcomes of patients undergoing primary percutaneous coro- nary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial. Cardiovasc Revasc Med, 2014, 15:375-380.
  • 6Sunman HI, Yorgun H, Canpolat U, et al. Association between family history of premature eoronary artery disease and coronary atheroselerotie plaques shown by multideteetor computed tomo- graphy coronary angiography. Int J Cardiol, 2013, 164:355-358.
  • 7Stampfer M J1, Krauss RM, Ma J, et al. A prospective study of triglyeeride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA, 1996, 276:882-888.
  • 8Billinger M1, Raber L, Hits S, Stefanini GG, et al. Long-term clinical and angiographic outcomes of diabetic patients after revas- cularization with early generation drug-eluting stents. Am Heart J, 2012, 163:876-886.
  • 9Nikolsky E1, Aymong ED, Halkin A, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary per- cutaneous coronary intervention : analysis from the Controlled Ab-ciximab and Device Investigation to Lower Late Angioplasty Com- plications (CADILLAC) Trial. J Am Coil Cardiol, 2004, 44 : 547-553.
  • 10Gagnon DR1, Zhang TJ, Brand FN, et al. Hematoerit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J, 1994, 127:674-682.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部